Posts tagged: Neil Woodford
Friday, 29 November 2019, 2:20 pm
The market was a tad surprised by this morning's announcement about Northgate's all-share merger of Redde, which provides replacement vehicle, repair and recovery services to insurance company customers.
Not least because just a couple of days ago around 45 million Redde shares changed hands, which effectively saw Neil Woodford's defunct outfit (now controlled by Blackrock) and his old colleague Mark Barnett of Invesco Perputual cleared out (or partially cleared out) of the stock...
Read more...
Betaville IntelligenceFriday, 19 July 2019, 4:31 pm
Betaville takes a lot of stick from punters about my jackanories, so below is a link that effectively confirms this week's RARE Alert about Woodford Investment Management placing its near 17pc stake in wily old Richard Bernstein's Crystal Amber Fund...
Read more...
Saturday, 22 June 2019, 9:57 am
So, the mystery surrounding the shareholding shuffle at Oxford Nanopore Technologies might not actually be a mystery after all!
Back in March it emerged, according to the venerable Financial Times, that after Oxford Nanopore told Woodford of its floatation plans the fund manager was able to sell his 2.15 million shares back to the company, which were cancelled and then reissued as new securities...
Read more...
Wednesday, 19 June 2019, 7:20 pm
The mystery surrounding the shareholding shuffle at Oxford Nanopore Technologies continues with a fresh announcement today at Companies House regarding a statement of capital. Below is the link:
https://beta.companieshouse.gov.uk/company/05386273/filing-history
I wonder what could be going on at the highly-valued firm?..
Read more...
Tuesday, 18 June 2019, 9:33 pm
Ping!
A loyal reader gets in touch to point out that there has been a substantial change in the shareholding structure of Oxford Nanopore Technologies, the gene-sequencing company that received investment from beleguered fund manager Neil Woodford.
Below is a link to the Companies House filing history that shows today's purchase of shares and allotment of shares at Oxford Nanopore Technologies:..
Read more...
Tuesday, 10 July 2018, 8:37 am
Sensyne Health, the start up healthcare technology business funded by controversial (star?) fund manager Neil Woodford, is pressing ahead with a float on London's AIM market.
Sources familiar with the situation said Sensyne, formerly known as Drayson Health, has hired brokers from Peel Hunt to work on the listing...
Read more...